Piper Sandler analyst Tyler Van Buren reiterated an Overweight rating and $35.00 price target on Nurix (NASDAQ: NRIX).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Wells Fargo Reiterates Overweight Rating on Nurix (NRIX)October 15, 2024 6:19 AM